Journal of Applied Genetics, Journal Year: 2024, Volume and Issue: 65(3), P. 627 - 634
Published: May 10, 2024
Language: Английский
Journal of Applied Genetics, Journal Year: 2024, Volume and Issue: 65(3), P. 627 - 634
Published: May 10, 2024
Language: Английский
Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 253, P. 155093 - 155093
Published: Jan. 1, 2024
Language: Английский
Citations
6Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 253, P. 155087 - 155087
Published: Jan. 1, 2024
Language: Английский
Citations
4International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(8), P. 3570 - 3570
Published: April 10, 2025
Asthma and atherosclerosis are chronic conditions with distinct pathophysiologies, but overlapping inflammatory mechanisms that suggest a potential common regulatory framework. MicroRNAs (miRNAs), small non-coding RNA molecules modulate gene expression post-transcriptionally, could be key players in linking these disorders. This review outlines how miRNAs contribute to the complex interplay between asthma atherosclerosis, focusing on involved pathways, immune cell regulation vascular remodeling. We discuss specific miRNAs, such as miR-155, miR-21 miR-146a, which have been shown cytokine production T differentiation, impacting respiratory cardiovascular health. The found both emphasize their role biomarkers, also therapeutic targets. Understanding molecular connections may unlock novel approaches for innovative, integrated treatment strategies address significantly improve patient outcomes. Further research is needed explore mechanistic pathways validate translational of miRNA-based interventions preclinical clinical settings.
Language: Английский
Citations
0Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 253, P. 155085 - 155085
Published: Jan. 1, 2024
Language: Английский
Citations
1Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 254, P. 155102 - 155102
Published: Jan. 9, 2024
Language: Английский
Citations
1Heliyon, Journal Year: 2024, Volume and Issue: 10(6), P. e27694 - e27694
Published: March 1, 2024
BackgroundBronchial asthma is a persistent inflammatory respiratory condition that restricts the passage of air and causes hyperresponsiveness. Chronic can be classified into three categories: mild, moderate, severe. Remodeling took place as extracellular matrix accumulated in walls airways. Inflammation occurs result damage caused by metalloproteinase-2 (MMP-2) to basement membrane type IV collagen. The severity may associated with miR-196a2. objective our study was investigate underlying mechanisms clinical relevance miR-196a2 MMP-2 serum levels relation asthma.MethodsThis recruited 85 controls 95 asthmatics or Expression measured quantitative reverse transcriptase PCR. Using enzyme-linked immunosorbent assay (ELISA), MMP-2, IL-6, total immunoglobulin E (IgE) various grades were compared control group. MMP-2's diagnostic prognostic potential determined using ROC curve analysis. This also blood Eosinophils PFTs. We examined connections IgE, Eosinophils, PFTs.ResultsThe current investigation found expression significantly higher group than asthmatic patients whole. severe had IgE healthy controls. identified concentration cutoff great sensitivity specificity. Significant relationships between level patient found. considerably correlated positively eosinophils % negatively all lung function tests group.Conclusion: revealed elevated pathophysiology degree severity. have promising ability bronchial asthma.
Language: Английский
Citations
1Journal of Applied Genetics, Journal Year: 2024, Volume and Issue: 65(3), P. 627 - 634
Published: May 10, 2024
Language: Английский
Citations
0